Rationale: Cocaethylene is a pharmacologically active homolog and metabolit
e of cocaine, formed by transesterification of cocaine in the presence of e
thanol. Here we relate findings from a randomized, placebo-controlled, doub
le-blind study in which we examined the physiological and subjective effect
s and pharmacokinetics of IV administered cocaethylene in human volunteers
using cocaine as a comparator. Methods: Cocaine-dependent participants rand
omly received one study drug, cocaethylene (0.25 or 0.5 mg/kg), cocaine (0.
25 or 0.5 mg/kg), or placebo, during each experimental session which occurr
ed on separate days. Results: Cocaethylene was less potent in elevating hea
rt rate than equivalent doses of cocaine. Similar differences between cocai
ne and cocaethylene were found for subjective measures ("Cocaine High", "Ru
sh", "Stimulated" and "Good Drug Effects"). All active drug conditions prod
uced significant increases in systolic blood pressure relative to placebo,
but no significant effect on diastolic blood pressure was observed. Cocaeth
ylene demonstrated a slower clearance, larger volume of distribution and co
rrespondingly longer elimination half-life than cocaine. Conclusion: The fi
ndings from this study confirm those of previous studies that show that coc
aethylene has pharmacological properties in common with cocaine, but is les
s potent.